Ongoing pregnancies after vitrification of human oocytes using a combined solution of ethylene glycol and dimethyl sulfoxide

被引:73
作者
Selman, Helmy
Angelini, Antonio
Barnocchi, Nicoletta
Brusco, Gian Francesco
Pacchiarotti, Arianna
Aragona, Cesare
机构
[1] Univ Perugia, Ctr Sterilita & Fecondaz Assistita, Policlin Perugia, I-06121 Perugia, Italy
[2] Praxi Prov, Rome, Italy
[3] Univ Roma La Sapienza, Rome, Italy
关键词
dimethyl sulfoxide; ethylene glycol; human MII oocyte; pregnancy; vitrification;
D O I
10.1016/j.fertnstert.2006.02.117
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate a vitrification solution using a mixture of two cryprotetant agents, dimethyl sulfoxide and ethylyne glycol plus sucrose, on the survival of human oocytes. Design: Clinical study of cryopreservation of human metaphase 11 (MU), oocytes by vitrification. Setting: University-affiliated IVF center. Patient(s): Infertile couples who agreed to have their surplus oocytes vitrified,during the fresh IVF cycle. Intervention(s): Vitrification of surplus oocytes subsequently used in the next cycle and assisted fertilization by 11 intracytoplasmic sperm injection. Main Outcome Measure(s): Morphologic survival and normal fertilization',embryo development, and clinical outcome. Result(s): A total of 53 surplus MII oocytes from 6 patients were vitrified, of which 24 were thawed, resulting in 18 which survived morphologically (75%). Following insemination 14 of the 18 surviving eggs were fertilized (77.7%). All zygotes developed into viable embryos that were replaced into each patient's uterus, resulting in two healthy pregnancies: one singleton and one twin. The pregnancies were ongoing. Conclusion(s): Cryopreservation of human MII oocytes by vitrification appears to be a promising procedure, though to assure optimal effectiveness of this protocol further studies should be undertaken.
引用
收藏
页码:997 / 1000
页数:4
相关论文
共 26 条
[1]  
Agca Y, 1998, MOL REPROD DEV, V49, P408, DOI 10.1002/(SICI)1098-2795(199804)49:4&lt
[2]  
408::AID-MRD8&gt
[3]  
3.0.CO
[4]  
2-R
[5]   Pregnancies and births after oocyte cryopreservation [J].
Borini, A ;
Bonu, MA ;
Coticchio, G ;
Bianchi, V ;
Cattoli, M ;
Flamigni, C .
FERTILITY AND STERILITY, 2004, 82 (03) :601-605
[6]   Successful pregnancies and deliveries after a simple vitrification protocol for day 3 human embryos [J].
El-Danasouri, I ;
Selman, H .
FERTILITY AND STERILITY, 2001, 76 (02) :400-402
[7]   CRYOPROTECTANT TOXICITY AND CRYOPROTECTANT TOXICITY REDUCTION - IN SEARCH OF MOLECULAR MECHANISMS [J].
FAHY, GM ;
LILLEY, TH ;
LINSDELL, H ;
DOUGLAS, MS ;
MERYMAN, HT .
CRYOBIOLOGY, 1990, 27 (03) :247-268
[8]   SOME EMERGING PRINCIPLES UNDERLYING THE PHYSICAL-PROPERTIES, BIOLOGICAL ACTIONS, AND UTILITY OF VITRIFICATION SOLUTIONS [J].
FAHY, GM ;
LEVY, DI ;
ALI, SE .
CRYOBIOLOGY, 1987, 24 (03) :196-213
[9]   Improved vitrification solutions based on the predictability of vitrification solution toxicity [J].
Fahy, GM ;
Wowk, B ;
Wu, J ;
Paynter, S .
CRYOBIOLOGY, 2004, 48 (01) :22-35
[10]   Cryopreservation of human germinal vesicle stage and in vitro matured M II oocytes: influence of cryopreservation media on the survival, fertilization, and early cleavage divisions [J].
Goud, A ;
Goud, P ;
Qian, C ;
Van der Elst, J ;
Van Maele, G ;
Dhont, M .
FERTILITY AND STERILITY, 2000, 74 (03) :487-494